Igor Aurer
-
- Lymphoma Diagnosis and Treatment 60
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 26
- Oncology top 10%
- Viral-associated cancers and disorders 17
- COVID-19 and healthcare impacts 6
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 7
- Otorhinolaryngology top 10%
-
- CNS Lymphoma Diagnosis and Treatment 10
-
- Lung Cancer Treatments and Mutations 10
-
- Acute Lymphoblastic Leukemia research 8
- Co-authors
- Boris LabarIvo RadmanMirando MršićR P GaleZdravko MitrovićDubravka SertićSandra Bašić‐KindaJasminka Jakić‐Razumović
- Partner nations
- CroatiaNetherlandsItaly
In The Last Decade
Igor Aurer
75 papers receiving 929 citations
Peers
Comparison fields: 5 of 68
- Pathology and Forensic Medicine 531
- Genetics 223
- Oncology 449
- Hematology 170
- Otorhinolaryngology 47
Countries citing papers authored by Igor Aurer
This map shows the geographic impact of Igor Aurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Aurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Aurer more than expected).
Fields of papers citing papers by Igor Aurer
This network shows the impact of papers produced by Igor Aurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Aurer. The network helps show where Igor Aurer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Igor Aurer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 5 | |
| 6 | 2019 | 2 | |
| 7 | 2019 | 35 | |
| 8 | 2018 | 4 | |
| 9 | 2017 | 18 | |
| 10 | 2016 | 26 | |
| 11 | 2012 | 4 | |
| 12 | 2011 | 1 | |
| 13 | 2010 | 13 | |
| 14 | Dvadeset godina liječenja teške aplastične anemije u Zavodu za hematologiju Klinike za unutrašnje bolesti Kliničkog bolničkog centra Zagreb | 2009 | 1 |
| 15 | 2009 | 19 | |
| 16 | 2009 | 24 | |
| 17 | 2008 | 3 | |
| 18 | 2006 | 2 | |
| 19 | High-Dose Ifosfamide and Mitoxantrone (HDIM) as Cytoreductive and Mobilisation Protocol for Relapsed and Refractory Lymphoma | 2003 | 1 |
| 20 | 2002 | 23 |
About Igor Aurer
Igor Aurer is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 88 papers that have together received 950 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (60 papers), Chronic Lymphocytic Leukemia Research (26 papers), Viral-associated cancers and disorders (17 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (10 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and COVID-19 and healthcare impacts (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (531 citations), Genetics (223 citations) and Oncology (449 citations). Igor Aurer has collaborated with scholars based in Croatia, Netherlands and Italy. Frequent co-authors include Boris Labar, Ivo Radman, Mirando Mršić, R P Gale, Zdravko Mitrović, Dubravka Sertić, Sandra Bašić‐Kinda, Jasminka Jakić‐Razumović, Anna Sureda and Dan Nemet. Their work appears in journals such as HemaSphere, Blood, Biomedicines, Journal of Clinical Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.